Safety and efficacy of Clopidogrel versus Aspirin in the prevention of Ischemic Stroke in Chinese patients from Beijing medical insurance database

Trial Profile

Safety and efficacy of Clopidogrel versus Aspirin in the prevention of Ischemic Stroke in Chinese patients from Beijing medical insurance database

Completed
Phase of Trial: Phase III

Latest Information Update: 27 May 2016

At a glance

  • Drugs Clopidogrel (Primary) ; Aspirin
  • Indications Stroke
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 27 May 2016 New trial record
    • 25 May 2016 Results presented at the 21st Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top